Search
Feed aggregator
Convicted ‘Pharma Bro’ Shkreli's Vyera Files for Bankruptcy
Convicted ‘Pharma Bro’ Shkreli's Vyera Files for Bankruptcy 5/11/2023
Pharma, PBMs Blame Each Other Under Intense Scrutiny from Sanders’ Health Committee
Pharma, PBMs Blame Each Other Under Intense Scrutiny from Sanders’ Health Committee 5/11/2023
Gout Disease Control Suffered After FDA-Driven Price Hike: Study
Gout Disease Control Suffered After FDA-Driven Price Hike: Study 5/11/2023
What You Need to Know to Launch a Biotech Startup
What You Need to Know to Launch a Biotech Startup 5/11/2023
FDA Approves First Drug for Agitation in Alzheimer's Dementia: Update
FDA Approves First Drug for Agitation in Alzheimer's Dementia: Update 5/11/2023
Moving from Tech to Biotech: Benefits, Challenges & Advice from Experts
Moving from Tech to Biotech: Benefits, Challenges & Advice from Experts 4/11/2023
HI-Bio Advances Rare Kidney Disease Therapy to Late-Stage Studies
HI-Bio Advances Rare Kidney Disease Therapy to Late-Stage Studies 4/11/2023
A New Era: Treating Negative Symptoms in Schizophrenia
A New Era: Treating Negative Symptoms in Schizophrenia 4/11/2023
Metabolite tells cells whether to repair DNA
Metabolites called nucleotides are the building blocks of DNA and can impact cancer's sensitivity or resistance to chemotherapy and radiation in brain cancer.
Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite, called GTP, controls responses to radiation and chemotherapy in an unexpected way.
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up 11/3/2023
Lexeo Therapeutics Launches $100M IPO to Fund Cardio, Alzheimer’s Candidates
Lexeo Therapeutics Launches $100M IPO to Fund Cardio, Alzheimer’s Candidates 11/3/2023
Regeneron’s Eylea Sales Decline in Q3, Battle with Roche’s Vabysmo Heats Up
Regeneron’s Eylea Sales Decline in Q3, Battle with Roche’s Vabysmo Heats Up 11/3/2023
Neurocrine Touts Phase III Huntington’s Data, Posts 29% YoY Growth
Neurocrine Touts Phase III Huntington’s Data, Posts 29% YoY Growth 11/3/2023
Confidence and Caution as AI Predicts Drug Safety
Confidence and Caution as AI Predicts Drug Safety 11/3/2023
HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit
HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit 11/3/2023
Novel Immune Modulator Has Potential to Change Treatment Approach in Rheumatoid Arthritis and Ulc...
Novel Immune Modulator Has Potential to Change Treatment Approach in Rheumatoid Arthritis and Ulc... 11/3/2023
Bayer and Broad Institute of MIT and Harvard extend research collaboration to develop new cancer therapies
Bayer and the Broad Institute of MIT and Harvard today announced that they have extended their research collaboration of 10 years by an additional five years, to develop and advance innovative cancer treatments. The expanded agreement will focus on joint cancer target identification and discovery of new therapeutic approaches in oncology.
Novo Logs Over 700% Wegovy Sales Growth in Q3, Raises 2023 Outlook
Novo Logs Over 700% Wegovy Sales Growth in Q3, Raises 2023 Outlook 11/2/2023
Lilly’s Mounjaro Beats Q3 Expectations, But Company Cuts Full-Year Profit Guidance
Lilly’s Mounjaro Beats Q3 Expectations, But Company Cuts Full-Year Profit Guidance 11/2/2023
Moderna Posts Q3 Loss, Takes $1.3B in Write-Downs on COVID-19 Shots
Moderna Posts Q3 Loss, Takes $1.3B in Write-Downs on COVID-19 Shots 11/2/2023
World Pharma News
- The risk of cardiovascular disease can be reduced by eating more oily fish
- New technique efficiently offers insight into gene regulation
- Pfizer announces topline Phase 2b results of oral GLP-1R agonist, danuglipron, in adults with obesity
- A patch of protection against Zika virus
- Scientists uncover how fermented-food bacteria can guard against depression, anxiety